Saskatoon, Canada

Bharathikumar Vellalore Maruthachalam

This inventor holds 1 USPTO granted patent. Top assignee: University of Saskatchewan. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bharathikumar Vellalore Maruthachalam. Retrieved from https://idiyas.com/inventor/bharathikumar-vellalore-maruthachalam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bharathikumar Vellalore Maruthachalam: Innovator in HER3 Binding Agents

Introduction

Bharathikumar Vellalore Maruthachalam is a notable inventor based in Saskatoon, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of HER3 binding agents. His work focuses on creating antibodies that specifically target HER3, a protein associated with various cancers.

Latest Patents

Bharathikumar holds 1 patent for his invention titled "HER3 binding agents and uses thereof." This patent encompasses antibodies and binding fragments that specifically bind to HER3. Additionally, it includes immunoconjugates that utilize these antibodies for detecting HER3-expressing cells and for treating HER3-expressing cancer.

Career Highlights

Bharathikumar is affiliated with the University of Saskatchewan, where he conducts his research and development activities. His innovative work has the potential to impact cancer treatment significantly, providing new avenues for therapeutic interventions.

Collaborations

Some of his notable coworkers include Ayman Elsayed Mohammad and Jianghai Liu. Their collaborative efforts contribute to the advancement of research in the field of cancer therapeutics.

Conclusion

Bharathikumar Vellalore Maruthachalam is a pioneering inventor whose work on HER3 binding agents showcases the potential for innovative solutions in cancer treatment. His contributions to biotechnology are noteworthy and reflect a commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…